Education
About Us
Working with TipRanks
Follow Us
PharmaSGP Holding SE (DE:PSG)
XETRA:PSG
Total Valuation
PharmaSGP Holding SE has a market cap or net worth of €338.40M. The enterprise value is €298.49M.
Market Cap€338.40M
Enterprise Value€298.49M
Share Statistics
PharmaSGP Holding SE has 12,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PharmaSGP Holding SE’s return on equity (ROE) is 0.61 and return on invested capital (ROIC) is 22.61%.
Return on Equity (ROE)0.61
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)22.61%
Return on Capital Employed (ROCE)0.30
Revenue Per Employee1.31M
Profits Per Employee214.67K
Employee Count91
Asset Turnover1.04
Inventory Turnover1.04
Valuation Ratios
The current PE Ratio of PharmaSGP Holding SE is 15.20. PharmaSGP Holding SE’s PEG ratio is 3.99.
PE Ratio15.20
PS Ratio0.00
PB Ratio8.94
Price to Fair Value9.29
Price to FCF15.83
Price to Operating Cash Flow14.77
PEG Ratio3.99
Income Statement
In the last 12 months, PharmaSGP Holding SE had revenue of 118.84M and earned 19.54M in profits. Earnings per share was 1.65.
Revenue118.84M
Gross Profit107.99M
Operating Income27.64M
Pretax Income26.04M
Net Income19.54M
EBITDA39.59M
Earnings Per Share (EPS)1.65
Cash Flow
In the last 12 months, operating cash flow was 22.18M and capital expenditures -1.53M, giving a free cash flow of 20.65M billion.
Operating Cash Flow22.18M
Free Cash Flow20.65M
Free Cash Flow per Share1.72
Dividends & Yields
PharmaSGP Holding SE pays an annual dividend of €0.51, resulting in a dividend yield of 1.81%
Dividend Per Share€0.51
Dividend Yield1.81%
Payout Ratio42.46%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.06
52-Week Price Change30.80%
50-Day Moving Average27.05
200-Day Moving Average25.34
Relative Strength Index (RSI)53.22
Average Volume (3m)3.82K
Important Dates
PharmaSGP Holding SE upcoming earnings date is Sep 25, 2025, TBA (Confirmed).
Last Earnings DateMay 28, 2025
Next Earnings DateSep 25, 2025
Ex-Dividend DateJun 26, 2025
Financial Position
PharmaSGP Holding SE as a current ratio of 2.33, with Debt / Equity ratio of 2.35%
Current Ratio2.33
Quick Ratio1.88
Debt to Market Cap0.00
Net Debt to EBITDA-0.64
Interest Coverage Ratio6.31
Taxes
In the past 12 months, PharmaSGP Holding SE has paid 6.50M in taxes.
Income Tax6.50M
Effective Tax Rate0.25
Enterprise Valuation
PharmaSGP Holding SE EV to EBITDA ratio is 6.85, with an EV/FCF ratio of 11.59.
EV to Sales2.28
EV to EBITDA6.85
EV to Free Cash Flow11.59
EV to Operating Cash Flow10.91
Balance Sheet
PharmaSGP Holding SE has €29.32M in cash and marketable securities with €860.00K in debt, giving a net cash position of -€28.46M billion.
Cash & Marketable Securities€29.32M
Total Debt€860.00K
Net Cash-€28.46M
Net Cash Per Share-€2.37
Tangible Book Value Per Share-€2.26
Margins
Gross margin is 90.55%, with operating margin of 23.26%, and net profit margin of 16.44%.
Gross Margin90.55%
Operating Margin23.26%
Pretax Margin21.91%
Net Profit Margin16.44%
EBITDA Margin33.32%
EBIT Margin25.40%
Analyst Forecast
The average price target for PharmaSGP Holding SE is €37.63, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€37.63
Price Target Upside33.44% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast13.80%
EPS Growth Forecast10.94%